Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
03/2006
03/02/2006CA2571132A1 Novel compounds having an anti-bacterial activity
03/01/2006EP1630162A1 2-aminoquinoline derivative
03/01/2006EP1629841A1 Antidepressants or food and drinks for antidepression
03/01/2006EP1628970A2 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
03/01/2006EP1628969A1 Benzopyran derivatives substituted with a benzimidazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
03/01/2006EP1628968A1 4-imidazolin-2-one compounds
03/01/2006EP1628966A2 4-amino-2(5h)-furanones useful as cholecystokinin antagonists
03/01/2006EP1628957A1 Sulfopyrroles
03/01/2006EP1628661A2 Modulators of vr1 receptor
03/01/2006EP1628619A2 4-aminopyrimidine-5-one
03/01/2006EP1628532A2 Methods for the protection of memory and cognition
03/01/2006EP1278520B1 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents
03/01/2006EP1233962B1 Novel heterocyclic compounds and their use as medicines
03/01/2006EP0842923B1 Pyrrole derivatives and medicinal composition
03/01/2006CN1742008A Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them
03/01/2006CN1742007A Indole-derivative modulators of steroid hormone nuclear receptors
03/01/2006CN1742006A Benzofurane derivatives and the use of the same as antidepressants and anxiolytics
03/01/2006CN1741999A Pyridazinone derivatives as GSK-3beta inhibitors
03/01/2006CN1741995A Isoindoline derivative
03/01/2006CN1741986A Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
03/01/2006CN1740173A Inhibitors of interleukin-1beta converting enzyme
03/01/2006CN1740151A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/01/2006CN1740150A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/01/2006CN1243756C Process and ester derivatives for preparing cephalosporins
03/01/2006CN1243751C Piperidine compounds as anti-allergic medicine
03/01/2006CN1243750C 4-,5-,6-and 7-indole derivatives useful for treatment of CNS disorders
03/01/2006CN1243746C Heterocyclic compound inhibiting angiogenesis
03/01/2006CN1243735C 2-lminopyrrolidine derivatives
02/2006
02/28/2006US7005448 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
02/28/2006US7005444 3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
02/28/2006US7005440 Therapeutic uses of tri-aryl acid derivatives
02/28/2006US7005439 Compounds
02/28/2006US7005438 Pharmaceutically active isoindoline derivatives
02/28/2006US7005436 Heterocyclo inhibitors of potassium channel function
02/28/2006US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
02/28/2006CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/28/2006CA2180444C Water soluble onium salt of taxo-diterpenoid
02/24/2006CA2533320A1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
02/23/2006WO2006020879A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
02/23/2006WO2006019116A1 Photoreactive compound, photoreactive polyamine and method for producing polyamine sheet
02/23/2006WO2006018973A1 Oxime ester compound and photopolymerization initiator containing such compound
02/23/2006WO2006018855A1 Novel antidiabetic compounds
02/23/2006WO2006018708A2 Pyrrolidine derivatives as muscarinic receptor antagonists
02/23/2006WO2006018443A1 Heterocyclic condensed compounds useful as antidiuretic agents
02/23/2006WO2006018284A1 Compounds and compositions useful as cathepsin s inhibitors
02/23/2006WO2006018260A1 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h 3 receptor
02/23/2006WO2005123688A3 3-aminoindazoles
02/23/2006WO2005115145A3 Quinone substituted quinazoline and quinoline kinase inhibitors
02/23/2006WO2005053614A3 Advanced indolinone based protein kinase inhibitors
02/23/2006WO2005048953A3 Amide derivatives as kinase modulators
02/23/2006WO2005003086A3 Sulfonic acid derivatives of polycyclic dyes used for analytical applications
02/23/2006US20060041142 demetallization to prepare of 2,4'-bipyridine, 4-methyl-2-(2'-pyridyl)pyridine, 2,3'-bipyridine, 6-chloro-2-(2'-thienyl)pyridine, or 2-(3'-thienyl)pyridine; synthetic intermediate for fungicides
02/23/2006US20060041139 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity
02/23/2006US20060041138 Process for producing paroxetine hydrochloride hydrate
02/23/2006US20060041132 Novel triazolo pyrimidine compounds
02/23/2006US20060041123 Antibacterial agents
02/23/2006US20060041034 Polyoxo derivatives of bis(pyrimidinylidene)-, bis(indanylidene)-, bis(dioxanylidene)- and bis(pyrazolylidene)- condensates of bisisoindolylidenes, e.g., 3,3'-Bis(1,3-dioxoindan-2-ylidene)-[1,1']biisoindolylidene and 3,3'-Bis(1,3-dimethyl-2,4,6-trioxotetrahydropyrimidin-5-ylidene)-[1,1']biisoindolylidene
02/23/2006US20060041000 Hydantoin derivatives; for treatment of asthma, chronic obstructive pulmonary diseases (COPD), arthritis, cancer, heart disease and nephritis
02/23/2006US20060040995 Method for preparing hydroxypicolinic scid derivatives
02/23/2006US20060040994 Substituted amide beta secretase inhibitors
02/23/2006US20060040990 Epothilone derivatives, process for their production, and their pharmaceutical use
02/23/2006US20060040988 antiinflammatory, antipyretic and analgesic agents; side effects redution; N-(cyclohexylmethyl)-6-[4-(methylsulfonyl)phenyl]-4-(trifluoromethyl)-2-pyridinamine; osteoarthritis; rheumatoid arthritis
02/23/2006US20060040973 Novel guanidine mimics as factor Xa inhibitors
02/23/2006US20060040968 2-(Amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
02/23/2006US20060040967 6-Fluoroalkyl-4-(5-sulfonyl-2-pyridyl)-substituted, e.g., 4-(5-Methanesulfonyl-pyridin-2-yl)-6-trifluoromethyl-pyrimidin-2-yl]-methyl-(6-methyl-pyridin-2-ylmethyl)-amine; treating pain, fever and inflammation without the potential side effects of other COX inhibitors
02/23/2006US20060040966 e.g. 2-(7-isoquinolinylamino)-N-(3-methyl-4-(1-methylethyl)phenyl)-3-pyridinecarboxamide; Vascular Endothelial Growth Factor antagonist; angiogenesis inhibitor; anticarcinogenic, antiinflammatory inhibitor; retinopathies, rheumatoid arthritis, asthma, atherosclerosis, endometriosis, neoplastic diseases
02/23/2006US20060040956 Substituted alkylamine derivatives and methods of use
02/23/2006US20060040954 Soluble amide & ester pyrazinoylguanidine sodium channel blockers
02/23/2006US20060040950 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
02/23/2006US20060040949 Treating antibiotic resistant bacterial infections; compounds based on quinoline rings; (3S)-2-(3-{[(Benzo[1,2,5]thiadiazol-5-ylmethyl)-amino]-methyl}-piperidin-1-yl)-(1RS)-(6-methoxy-quinolin-4-yl)-ethanol for example
02/23/2006US20060040947 inflammation; N-(4-Phenylpyridin-2-yl)isoquinolin-5-amine; analgesis; antinociceptive agents
02/23/2006US20060040939 Benzamide inhibitors of the P2X, receptor
02/23/2006US20060040923 1,1-Diethyl-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-urea; respiratory syncytial virus; cost efficient replacement for Synagis (palivizumab) used for RSV; respiratory system disorders; asthna; viral diseases; myxoviruses; mumps; flaviviruses; dengue, West Nile, parainfluenza viruses
02/23/2006US20060040918 Benzo d!azepine derivatives for the treatment of neurological disorders
02/23/2006US20060040906 Piperazine urea derivatives as melanocortin-4 receptor agonists
02/23/2006CA2581327A1 Intracellular receptor modulator compounds and methods
02/23/2006CA2577668A1 Novel antidiabetic compounds
02/23/2006CA2576531A1 1,5-diphenylpyrazoles
02/23/2006CA2575853A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
02/23/2006CA2575826A1 Compounds and compositions useful as cathepsin s inhibitors
02/23/2006CA2573730A1 1,2,3,4-tetrahydropyrazin-2-yl acetamides and their use as bradykinin antagonists for the treatment of inflammation related disorders
02/23/2006CA2567782A1 Heterocyclic condensed compounds useful as antidiuretic agents
02/22/2006EP1627876A1 Heterocyclic condensed compounds useful as antidiuretic agents
02/22/2006EP1627873A1 Benzofuran compound and medicinal composition containing the same
02/22/2006EP1627870A1 Cyanofluoropyrrolidine derivative
02/22/2006EP1626967A1 Substituted pyrazoles
02/22/2006EP1626966A1 Benzofuran inhibitors of factor viia
02/22/2006EP1626964A2 New benzimidazole derivatives
02/22/2006EP1626962A1 Benzamide inhibitors of the p2x7 receptor
02/22/2006EP1626960A1 Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists
02/22/2006EP1626959A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
02/22/2006EP1626720A1 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
02/22/2006EP1414812B1 Hydroxamic acid derivatives
02/22/2006EP1237874B1 Selective neurokinin antagonists
02/22/2006EP1105375B1 Trifluoromethylpyrrolcarboxamides useful as fungicides
02/22/2006CN1738814A Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
02/22/2006CN1738807A Substituted aralkyl derivatives
02/22/2006CN1738805A N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as CGRP-antagonists for treating a headache
02/22/2006CN1738804A 吡唑化合物 Pyrazole compounds
02/22/2006CN1738801A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof